Anticancer drugs and/or biologics are prescription medications taken by mouth or injected into the body that are used to kill or slow the growth of cancerous cells.
Supportive agents are defined as drugs and biologics that are prescribed to prevent, control, or treat severe adverse health conditions experienced as a direct result of cancer, not for the adverse effects caused by the treatments. The Commonwealth of Pennsylvania's >Act 6 of 2020< or >Fair Access to Cancer Treatment Act requires coverage of supportive agents for individuals with Stage four, advanced metastatic cancer.
Off-label use of prescription drugs and/or biologics can include factors such as indications, dosages, frequencies, or routes of administration that are inconsistent with US Food and Drug Administration (FDA) labeling. For off-label use, additional clinical rationale is required to support coverage.